Ketoacidosis in Individuals With Type I Diabetes Mellitus (T1DM)
NCT ID: NCT00970567
Last Updated: 2009-09-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
19 participants
INTERVENTIONAL
2007-11-30
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Oxytocin on the Alpha Cell Response to Hypoglycaemia in Patients With Type 1 Diabetes
NCT06881459
Diabetic Ketoacidosis: Brain Morphology and Cognition
NCT02443415
Very-Low-Density-Lipoprotein-Triglyceride(VLDL-TG) Metabolism During Acute Hyperglycemia
NCT01178957
Recurrent Hypoglycemia in Type 1 Diabetes (Aim 1)
NCT03410277
Diabetic Ketoacidosis Diagnosis and Management
NCT06327737
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1
stop after positive ketone bodies in urine
Different insulin therapy at different time points
different insulin therapy after positive blood ketones
Arm 2
stop after positive ketone bodies in blood, normal therapy
Different insulin therapy at different time points
different insulin therapy after positive blood ketones
Arm 3
stop after positive ketone bodies in blood, additional therapy
Different insulin therapy at different time points
different insulin therapy after positive blood ketones
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Different insulin therapy at different time points
different insulin therapy after positive blood ketones
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* acute illness
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott
INDUSTRY
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Charité-Universitätsmedizin Berlin, Department of Endocrinology, Diabetes and Nutrition
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joachim Spranger, MD
Role: STUDY_DIRECTOR
Charité, CBF
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charité-Universitätsmedizin Berlin, Department of Endocrinology, Diabetes and Nutrition
Berlin, State of Berlin, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EA4/039/07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.